Lyka Labs P/B Ratio
Lyka Labs (LYKALABS) P/B ratio is 2.17 (Moderate), book value per share ₹28.89 vs Healthcare average P/B of -0.94 — High - Premium to book value, growth expectations or asset-light model. Compare with LYKALABS DCF valuation to assess whether the stock is under or overvalued.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
LYKALABS P/B Ratio — Valuation Insights & Book Value Analysis
Lyka Labs price-to-book ratio interpretation, valuation status and historical context — current P/B 2.17 (Moderate). For live price, earnings yield and the full fundamental profile, see Lyka Labs share price today.
- Current PB is 80.9% below historical average
- Trading at premium to sector average PB of -0.94
Lyka Labs P/B Ratio Historical Trend
LYKALABS annual price-to-book ratio — 4 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View LYKALABS price range for the annual high/low range and current price position.
LYKALABS Historical P/B Ratio — Book Value Per Share & Year-End Price
Lyka Labs annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 2.63 | ₹28.89 | ₹75.89 | ₹104 | Moderate |
| 2024 | 7.66 | ₹20.61 | ₹157.82 | ₹68 | High |
| 2023 | 8.34 | ₹14.84 | ₹123.75 | ₹46 | High |
| 2022 | 26.87 | ₹4.83 | ₹129.70 | ₹14 | High |
LYKALABS vs Healthcare Peers — P/B Ratio Comparison
Lyka Labs P/B 2.17 vs Healthcare average -0.94, median 0.6 — range -31.21–1.03.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -31.21 | ₹25 | Low |
| Sun Pharma Advanced Rese… | SPARC | -16.05 | ₹5,310 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Parmax Pharma | PARMAX | -2.16 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.76 | ₹121 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |